Literature DB >> 22865286

Endoscopic evaluation of primary tumor response in patients with metastatic colorectal cancer treated by systemic chemotherapy.

Madoka Takao1, Kentaro Yamazaki, Narikazu Boku, Hisatomo Ikehara, Satoshi Hamauchi, Takahiro Tsushima, Hiroya Taniguchi, Akiko Todaka, Nozomu Machida, Akira Fukutomi, Yusuke Onozawa, Hirofumi Yasui.   

Abstract

BACKGROUND: The number of cases of metastatic colorectal cancer treated by chemotherapy without primary tumor resection has recently increased. However, evaluation of primary tumor response by computed tomography is difficult in such cases. In this study, the usefulness of evaluation of primary tumor response to chemotherapy by endoscopy was investigated.
METHODS: This retrospective analysis was performed at the Shizuoka Cancer Center and included 31 patients (88 evaluations) with metastatic colorectal cancer. Computed tomography and endoscopy were performed concomitantly between September 2002 and June 2006. Patients were treated by systemic chemotherapy without prophylactic primary tumor resection. Definitions of primary tumor response were as follows: (1) complete response, confirmed by colorectal biopsy; (2) progressive disease, enlargement of at least one of five tumor parameters; and (3) neither (1) nor (2). Computed tomography was performed to evaluate primary tumor response according to the Response Evaluation Criteria in Solid Tumors and to identify colorectal stenosis secondary to primary tumors.
RESULTS: The rate of concordance between endoscopy and computed tomography for evaluation of primary tumor response was 75%. Colorectal stenosis was detected 14 times by endoscopy (9 cases) and 3 times by computed tomography (3 cases). Of the 7 patients in whom surgery was required, 6 exhibited stenotic symptoms before endoscopic detection.
CONCLUSIONS: With regard to primary tumor response evaluation, a high concordance rate was observed between endoscopy and computed tomography, although endoscopic evaluation appeared more sensitive in detecting colorectal stenosis requiring surgical treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22865286     DOI: 10.1007/s10147-012-0452-2

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  11 in total

1.  Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer.

Authors:  A I Sarela; J A Guthrie; M T Seymour; E Ride; P J Guillou; D S O'Riordain
Journal:  Br J Surg       Date:  2001-10       Impact factor: 6.939

2.  Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases.

Authors:  S Benoist; K Pautrat; E Mitry; P Rougier; C Penna; B Nordlinger
Journal:  Br J Surg       Date:  2005-09       Impact factor: 6.939

3.  Use of surgery among elderly patients with stage IV colorectal cancer.

Authors:  Larissa K F Temple; Lillian Hsieh; W Douglas Wong; Leonard Saltz; Deborah Schrag
Journal:  J Clin Oncol       Date:  2004-09-01       Impact factor: 44.544

4.  FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.

Authors:  Christophe Tournigand; Thierry André; Emmanuel Achille; Gérard Lledo; Michel Flesh; Dominique Mery-Mignard; Emmanuel Quinaux; Corinne Couteau; Marc Buyse; Gérard Ganem; Bruno Landi; Philippe Colin; Christophe Louvet; Aimery de Gramont
Journal:  J Clin Oncol       Date:  2003-12-02       Impact factor: 44.544

5.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

6.  Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

Authors:  Leonard B Saltz; Stephen Clarke; Eduardo Díaz-Rubio; Werner Scheithauer; Arie Figer; Ralph Wong; Sheryl Koski; Mikhail Lichinitser; Tsai-Shen Yang; Fernando Rivera; Felix Couture; Florin Sirzén; Jim Cassidy
Journal:  J Clin Oncol       Date:  2008-04-20       Impact factor: 44.544

7.  Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.

Authors:  Charles S Fuchs; John Marshall; Edith Mitchell; Rafal Wierzbicki; Vinod Ganju; Mark Jeffery; Joseph Schulz; Donald Richards; Raoudha Soufi-Mahjoubi; Benjamin Wang; José Barrueco
Journal:  J Clin Oncol       Date:  2007-10-20       Impact factor: 44.544

8.  Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.

Authors:  George A Poultsides; Elliot L Servais; Leonard B Saltz; Sujata Patil; Nancy E Kemeny; Jose G Guillem; Martin Weiser; Larissa K F Temple; W Douglas Wong; Phillip B Paty
Journal:  J Clin Oncol       Date:  2009-06-01       Impact factor: 44.544

9.  Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases.

Authors:  N C Tebbutt; A R Norman; D Cunningham; M E Hill; D Tait; J Oates; S Livingston; J Andreyev
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

10.  Palliative resection of colorectal cancer: does it prolong survival?

Authors:  Renato Costi; Antonio Mazzeo; Davide Di Mauro; Licia Veronesi; Giuliano Sansebastiano; Vincenzo Violi; Luigi Roncoroni; Leopoldo Sarli
Journal:  Ann Surg Oncol       Date:  2007-05-31       Impact factor: 5.344

View more
  1 in total

Review 1.  Molecular imaging in gastroenterology.

Authors:  Raja Atreya; Martin Goetz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-16       Impact factor: 46.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.